Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.02), $0.22 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $47.87 million versus the consensus estimate of $105.7 million.

GUIDANCE:

Ironwood Pharma sees FY2024 revenue of $405-425 million, versus the consensus of $447.8 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.